P68-Clinical practice guidelines: Are we making a difference? Caroline Nehill, MPH (Presenter) (National Breast & Ovarian Cancer Centre, Surry Hills, New South Wales, Australia) PRIMARY TRACK: Guideline implementation SECONDARY TRACK: Guideline implementation methods BACKGROUND (INTRODUCTION): Clinical practice guidelines (CPG) are a key component of the National Breast and Ovarian Cancer Centre's (NBOCC) leadership in information provision on breast and ovarian cancer in Australia. In 2008, NBOCC published recommendations for use of sentinel node biopsy (SNB) in early (operable) breast cancer. The introduction of SNB is a major change to surgical technique for the assessment of the axilla, and represents a significant change in NBOCC's recommendations for women with breast cancer. While initially focusing on the development and dissemination of CPGs, NBOCC's recent emphasis has included implementation and evaluation of uptake. This project aims to explore a method of assessing the uptake of NBOCC CPGs, their impact on clinical practice, and the effectiveness of dissemination and implementation. LEARNING OBJECTIVES (TRAINING GOALS): 1. Describe a method of evaluating the impact of CPGs on clinical practice. 2. Describe a method of evaluating the effectiveness of dissemination and implementation of CPGs. METHODS: Specific practice recommendations were identified to be evaluated, along with appropriate measures, data items, and data sources. Data sources include cancer registry and clinical audit data sets. NBOCC undertook data collection where required. Data were stratified by geographical location for sub-analysis of metropolitan versus regional and rural findings.
RESULTS:
Results will be presented about the implementation of SNB nationally as a surgical technique in line with NBOCC recommendations. Sub-analysis will highlight any geographical differences to uptake and will consider patterns relating to differences in data sources.
DISCUSSION (CONCLUSION):
This project provides an opportunity to measure the impact of NBOCC guidelines on clinical practice and thereby gain an understanding of the translation of research into everyday practice. Barriers to the implementation of SNB according to CPGs will also be identified and will inform future initiatives to promote best practice in the management of women with early breast cancer. The project also provides baseline data for further evaluation. TARGET AUDIENCE(S): 1. Evidence synthesizer, developer of systematic reviews or meta-analyses 2. Guideline developer 3. Guideline implementer 4. Quality improvement manager/facilitator 5. Medical educator 6. Health care policy analyst/policy-maker 7. Medical providers and executives 8. Consumers and patients representatives
